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considered candidates for LV rehabilitation. MRI allows
quantification of LV blood flow, which is useful in patients
with an ASD and left-to-right atrial shunting. It is also more
sensitive than echocardiography for the detection of EFE, al-
though its sensitivity for recurrent EFE is unknown.16,17
Three-dimensional echocardiography allows surgical plan-
ning and has improved our understanding of the mechanisms
underlying the aortic and mitral valve pathology in this
population.
CONCLUSIONS
Primary LV rehabilitation procedure, when applied to
patients with borderline left heart structures and severe
EFE, allows maintenance of biventricular circulation with
low operative mortality. Further follow-up is needed to
establish whether the hemodynamic improvements will
translate into long-term survival and improvement in
quality of life.
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Dr Frank Hanley (Stanford, Calif). Our experience at Lucille
Packard Children’s Hospital is similar in that we have grappled
with this EFE problem as well. Our patients fall into 2 categories.
One category is similar to yours in this study, that is, non–duct-de-
pendent, slightly older children who have been managed interven-
tionally or surgically for LVOT obstruction, who then don’t do very
well. We have 5 patients in this group.
Addressing your point about teasing out the different compo-
nents of the repair, EFE resection, MV valve repair, and LVOT
revision, to determine which one is doing the trick, we have 1 pa-
tient who is approximately 1.5 years old and had a coarct repair and
aortic valve balloon dilation at another institution, with very good
results on both. This patient had a 15 mm Hg LVOT gradient and
only very mild mitral stenosis and mitral regurgitation combined,
but was failing, and at catheterization had an LV end-diastolic pres-
sure of 25 mmHg and pulmonary hypertension. So, this patient had
only EFE resection, with no mitral or aortic procedure. A year later,
he had a left atrial pressure of 9 mm Hg. So I think there is at least
some early evidence that it really is the EFE resection that is effec-
tive, not just that we’re doing something superfluous along with the
valve procedures.
We also had 1 patient with a reduced ejection fraction of 40%
late after EFE resection, although at catheterization the left atrial
pressure was down from 25 to 12 mm Hg. This is of concern.
The other category of our patients with EFE, the one that you
were kind enough to cite, is the neonatal duct-dependent patients
who underwent operation with EFE resection, Ross-Konno, Nor-
wood-type arch reconstruction, and sometimes mitral valve work.
There are 9 of these patients.
I took the opportunity to apply the ‘‘univentricular repair sur-
vival advantage score,’’ which you cited and applied to your patient
group, to several of these neonatal patients with Ross-Konno EFE.
Their survival scores ranged fromþ53 toþ85, much higher than the
score in the older non–duct-dependent patients, and so a very, very
different patient population.
With your group’s interest in staging the neonatal duct-depen-
dent patients and our interest in performing a primary Ross-Konno
in them, it is clear that the neonates are managed differently than the
older non–duct-dependent patients. Do you think we are at the
point now where we need to expand the definition of borderline
left heart disease, breaking them up into maybe 2 or 3 different sub-
categories within that designation, because there are distinctly dif-
ferent treatment approaches for these various patients?
Dr Emani. There are several approaches to the patient with
a borderline left heart and an LV that is salvageable. We have typ-
ically considered patients to be candidates for the primary LV reha-
bilitation if we have been able to achieve satisfactory function of
the aortic valve and biventricular circulation for a period of time.
Patients with severe hypoplasia of multiple left-sided structures,
Z-scores between 6 and 3, typically require single-ventricle
staged LV rehabilitation. This latter group is similar to your cohort
of patients with UVR-SA scores greater than 50.ardiovascular Surgery c Volume 138, Number 6 1281
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DIn patients undergoing staged LV rehabilitation, one interesting
finding is that we have been able to rehabilitate even the most
severely stenotic aortic valves such that only 2 of 9 patients have
required the Ross procedure, suggesting that there is growth poten-
tial of the left-sided structures. It is not obvious whether the neona-
tal Ross-Konno or staged LV rehabilitation is superior in the
patients with severe hypoplasia.
I think we need to make the distinction between these patients
and patients with EFE and a borderline left heart whom you might
be able to manage for a period of time with balloon dilations of the
aortic valve and coarctation repair, but who eventually develop
symptoms of congestive heart failure and right ventricular hyper-
tension. In these patients, clinical deterioration is our cue to proceed
with primary LV rehabilitation.
Dr Hanley. I take it you would tend to agree, then, that maybe
we need to have borderline category 1, borderline category 2,
maybe even a 3, because we are handling these patients within bor-
derline left heart differently.
Dr Emani. I think a major factor that helps us predict which pa-
tients with EFE might require staged versus the primary rehabilita-
tion relates to the sizes of the aortic valve, mitral valve, and LV. I
think the ventricles diminish in size compared with the body sur-
face area if no attempts are made to rehabilitate the left heart in in-
fancy. So there is some urgency to make this distinction early in
infancy and not wait until they’re older.
Dr Hanley. A very nice practical distinction is whether they are
duct-dependent or not, which correlates closely with the aortic and
mitral valves.
Dr Emani. I agree.
Dr Hanley. Now, a couple of more focused questions. You
catheterized, I think, 5 of these patients both before and after sur-
gery. It is encouraging to see the left atrial pressures come down;
there is no question about that. Did you take the opportunity, and
this again concerns your comment about the mitral and aortic valve
gradients not changing statistically, although you did significant
surgical work on it, to document the cardiac index to see if it
went up after surgery?
Dr Emani. In the 5 patients who had catheterization, there was
an apparent increase in cardiac output. However, I think that the
cardiac index measured by the Fick method at catheterization is1282 The Journal of Thoracic and Cardiovascular Ssomewhat subject to loading conditions and assumptions about ox-
ygen consumption. We frequently find that by the time they got to
the hemodynamics there were a lot of other inotropic and fluid ma-
nipulations, and so we have not placed much value on this measure-
ment; but statistically speaking, there was a difference in cardiac
index before and after. We’re trying to come up with more load-in-
dependent measures of function to get a feel for whether this is real
or not.
Dr Hanley. The third question relates to what I perceive as a cu-
rious part of the management plan, that is, leaving the ASD open in
some of the patients in your series. We all leave ASDs open in bor-
derline right hearts, where you want to reduce the right atrial pres-
sure and liver pressure, and so forth; but we all know that the
downside to that is less pulmonary blood flow, which is not oblig-
atory, so it’s fine.
With borderline left heart disease, the physiologic argument is
that you hurt the patient by leaving the ASD open, rather than
help. You might lower left atrial pressure, but the downside of
that is less loading conditions for the LV and less cardiac output.
The left side of the circulation doesn’t tolerate having a cardiac out-
put of 0.7. So I’m curious about the thinking that went into that part
of the decision making.
Dr Emani. Most of that comes from our experience with the
staged LV rehabilitation. We have had patients in whom a certain
stage is achieved after an EFE resection and mitral and aortic
valve work, and we take them to the catheterization laboratory
to balloon occlude the ASD and measure left atrial pressures.
In that series, there are some patients with elevated left atrial
pressures that would be considered prohibitive. Initially, in the
postoperative and primary LV rehabilitation period, we believe
the LV compliance actually gets worse before it gets better. In
many patients the left atrial pressure does increase within the
first 24 hours. We keep all these patients intubated/paralyzed
for 48 hours. We try to mitigate some of the fluctuations in
left atrial pressure by doing that.
Dr James Tweddell (Milwaukee, Wis). How did you define bor-
derline left heart for the purposes of this study?
Dr Emani. One or more of the left-sided structures having
a Z-score between3 and1, most often the aortic valve being
the smallest structure.urgery c December 2009
